These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31959424)

  • 41. Breakthrough varicella in a cancer patient with persistent varicella antibody after one varicella vaccination.
    Yamada M; Kamberos N; Grose C
    J Pediatr; 2013 Nov; 163(5):1511-3. PubMed ID: 23932212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Varicella vaccination in HIV-1-infected children after immune reconstitution.
    Bekker V; Westerlaken GH; Scherpbier H; Alders S; Zaaijer H; van Baarle D; Kuijpers T
    AIDS; 2006 Nov; 20(18):2321-9. PubMed ID: 17117018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England.
    Field N; Amirthalingam G; Waight P; Andrews N; Ladhani SN; van Hoek AJ; Maple PA; Brown KE; Miller E
    Vaccine; 2014 Feb; 32(10):1213-7. PubMed ID: 23871823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.
    Levin MJ; Gershon AA; Weinberg A; Song LY; Fentin T; Nowak B;
    J Infect Dis; 2006 Jul; 194(2):247-55. PubMed ID: 16779732
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.
    Hayashida K; Ozaki T; Nishimura N; Gotoh K; Funahashi K; Nakane K; Gomi Y; Manabe S; Ishikawa T; Yamanishi K
    J Immunol Methods; 2015 Nov; 426():50-5. PubMed ID: 26232696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
    Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
    J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Varicella-zoster virus immunity among health care workers in Catalonia.
    Urbiztondo L; Bayas JM; Broner S; Costa J; Esteve M; Campins M; Borrás E; Domínguez A;
    Vaccine; 2014 Oct; 32(45):5945-8. PubMed ID: 25219564
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of live varicella vaccine.
    Takahashi M
    Expert Opin Biol Ther; 2004 Feb; 4(2):199-216. PubMed ID: 14998778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of a commercial Varicella Zoster glycoprotein IgG enzyme immunoassay with a reference time resolved fluorescence immunoassay (VZV TRFIA) for measuring VZV IgG in sera from pregnant women, sera sent for confirmatory testing and pre and post vOka vaccination sera from healthcare workers.
    Maple PA; Breuer J; Quinlivan M; Kafatos G; Brown KE
    J Clin Virol; 2012 Mar; 53(3):201-7. PubMed ID: 22261123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neutralizing antibody responses induced by varicella-zoster virus gE and gB glycoproteins following infection, reactivation or immunization.
    Haumont M; Jurdan M; Kangro H; Jacquet A; Massaer M; Deleersnyder V; Garcia L; Bosseloir A; Bruck C; Bollen A; Jacobs P
    J Med Virol; 1997 Sep; 53(1):63-8. PubMed ID: 9298734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-level cellular and humoral immune responses in Guinea pigs immunized intradermally with a heat-inactivated varicella-zoster virus vaccine.
    Sarkadi J; Jankovics M; Fodor K; Kis Z; Takacs M; Visontai I; Jankovics I; Gonczol E
    Clin Vaccine Immunol; 2015 May; 22(5):570-7. PubMed ID: 25787138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.
    Amlie-Lefond C; Gilden D
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1561-1569. PubMed ID: 27138380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Varicella-zoster virus immunity in dermatological patients on systemic immunosuppressant treatment.
    Hackett CB; Wall D; Fitzgerald SF; Rogers S; Kirby B
    Br J Dermatol; 2011 Jun; 164(6):1387-9. PubMed ID: 21410679
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased incidence of herpes zoster in patients on renal replacement therapy cannot be explained by intrinsic defects of cellular or humoral immunity to varicella-zoster virus.
    Rondaan C; de Joode AAE; van Assen S; Bos NA; Westerhuis R; Westra J
    Antiviral Res; 2018 Oct; 158():206-212. PubMed ID: 30102958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection.
    Chris Maple PA; Gray J; Brown K; Brown D
    J Virol Methods; 2009 Apr; 157(1):90-2. PubMed ID: 19135089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
    Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
    J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine.
    Nader S; Bergen R; Sharp M; Arvin AM
    J Infect Dis; 1995 Jan; 171(1):13-7. PubMed ID: 7798653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proliferative response to varicella-zoster virus is inverse related to development of high levels of varicella-zoster virus specific IgG antibodies.
    Terada K; Kawano S; Yoshihiro K; Morita T
    Scand J Infect Dis; 1993; 25(6):775-8. PubMed ID: 8052820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group?
    Alfonsi V; Montomoli E; Manini I; Alberini I; Gentile C; Rota MC; Ciofi degli Atti ML
    Vaccine; 2007 Aug; 25(32):6086-8. PubMed ID: 17629374
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of Immune Response and Protective Immunity by a Local Isolated Varicella Virus in Animal Model: A Future Candidates for Vaccine Production.
    Esna-Ashari F; Sabahi F; Ravanshad M; Mohammadi A
    Iran J Allergy Asthma Immunol; 2018 Dec; 17(6):586-593. PubMed ID: 30644703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.